FIELD: pharmaceuticals.
SUBSTANCE: invention relates to pharmaceuticals, namely to method for producing a biologically active composite based on nanocrystalline cerium dioxide and curcumin, which can be used as or part of preparations for wound therapy, antioxidant, anti-inflammatory and antitumor drugs.
EFFECT: invention allows to obtain a biologically active composite based on nanocrystalline cerium dioxide and curcumin, which has reduced cytotoxicity and increased bioavailability.
1 cl, 3 ex, 4 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREPARING MEDICINE WITH METHIONINE AND TURMERIC EXTRACT IN GRANULAR TYPE WITH INTESTINAL SUSTAINABLE COATING OF SYSTEM ACTION | 2018 |
|
RU2684111C1 |
| METHOD FOR REDUCING CLONOGENIC ACTIVITY OF LACTEAL GLAND CANCER STEM CELLS | 2019 |
|
RU2700695C2 |
| METHOD FOR REDUCING THE NUMBER OF STEM CELLS OF BREAST CANCER | 2018 |
|
RU2702910C2 |
| METHOD FOR PREPARING STABILISER-COATED NANOCRYSTALLINE CERIUM DIOXIDE | 2012 |
|
RU2484832C1 |
| PHARMACOLOGICAL COMPOSITION FOR TREATING SECONDARY AMYLOIDOSIS | 2014 |
|
RU2557906C1 |
| COMPOSITION BASED ON CERIUM DIOXIDE NANOPARTICLES AND BROWN ALGAE POLYSACCHARIDES FOR TREATING WOUNDS | 2018 |
|
RU2699362C2 |
| AGENT, METHOD FOR ITS PREPARING AND METHOD FOR PROPHYLAXIS AND TREATMENT OF SMALL PELVIS ORGANS INFLAMMATORY DISEASE AND RECTUM DISEASE | 2004 |
|
RU2288735C2 |
| (17S)-N-BENZYL-5-((3Β-ACETOXY-28-NOR-URS-12-ENE)-17-YL)-1,3,4-OXADIAZOL-2-AMINE, HAVING SELECTIVE CELL CYTOTOXICITY BREAST CANCER MCF-7 | 2019 |
|
RU2708400C1 |
| METHOD FOR SUPPRESSING THE INDUCING ACTION OF HIGH MOLECULAR WEIGHT HYALURONIC ACID ON BREAST CANCER STEM CELLS | 2021 |
|
RU2774031C1 |
| PHARAMCEUTICAL COMPOSITION FOR TREATMENT OF ONCOLOGICAL DISEASES | 2012 |
|
RU2484814C1 |
